Juan MartosRosario Moreno Soldevila
Continuation of trastuzumab treatment as well as resection of BM seem to give further benefit in the treatment of patients with HER2-overexpressing MBC.
Ester Abreu Vieira de Oliveira
Aline Gonçalves de Castro ZaninViviane da Silva BatistaTerezinha Oliveira